Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXF9MO
|
||||
Drug Name |
{2-[4-(8-Chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-piperazin-1-yl]-2-oxo-ethyl}-carbamic acid tert-butyl ester
|
||||
Synonyms |
CHEMBL354742
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C25H31ClN4O3
|
||||
Canonical SMILES |
CC(C)(C)OC(=O)NCC(=O)N1CCN(CC1)C2c3ccc(Cl)cc3CCc4cccnc24
|
||||
InChI |
InChI=1S/C25H31ClN4O3/c1-25(2,3)33-24(32)28-16-21(31)29-11-13-30(14-12-29)23-20-9-8-19(26)15-18(20)7-6-17-5-4-10-27-22(17)23/h4-5,8-10,15,23H,6-7,11-14,16H2,1-3H3,(H,28,32)
|
||||
InChIKey |
KBTFXJQCDDPMJV-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.